Publicador de contenidos

REDIEX

Network of excellence in research and innovation in exosomas

Duración
20/11/2015-30/11/2017
Coordinador
Hernando A. del Portillo
Financiadores
MINECO
Página web
http://rediex.org/

Research on exosomes is increasingly appreciated in the clinical setting and it is likely that it will impact even more in the future. Exosomes have been found to carry selective biomarkers of disease, playing an essential role in the transfer of information and molecules between different cells involved in the regulation of several physiological and pathological processes.

This Network of Excellence for Research and Innovation on Exosomes (REDiEX) will focus its activity on strengthening the interaction between different Spanish groups that study this type of vesicles. REDiEX will integrate the experience and know-how of the different groups with a clear and innovative vision that will boost translational applications of vesicle analyses in human health. 

REDiEX will promote online and face-to-face scientific meetings, the mobility of personnel between the different laboratories and the optimization and attraction of resources to study several aspects of vesicle biology:

1) the development of new methodologies for the study of exosomes in animal models and patient samples;

2) the identification of non-invasive biomarkers;

3) search for novel therapeutic targets;

4) the analysis of intercellular communication processes mediated by exosomes in models of both development and cancer for the prediction of metastatic niches;

5) the role of exosomes as biomarkers and immune mediators and as a tool for diagnosis;

6) the development of vaccines against rare parasitic diseases.

Our overall objective is to develop and standardize methodologies, accelerating the identification and development of non-invasive biomarkers as well as define new strategies to tackle major diseases such as cancer and parasitic diseases.

Thus, REDiEX signifies a significant advance towards personalized medicine aiming to develop new tools and markers with high social impact that will generate economic benefits and equity in global health.

Total funding

46,000 €

 

Nuestro equipo

Principal Investigator

  • Hernando Del Portillo Obando
    Hernando Del Portillo Obando

ISGlobal Team

Otros proyectos

Ver proyectos pasados

NHEPACHA

Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas

Estudio inmunológico de la vacuna RTS,S

Estudio de correlatos de protección frente a la malaria después de la vacunación con RTS,S/AS01E: Una evaluación inmunológica exhaustiva en el ensayo clínico de Fase III, doble ciego, aleatorizado, multicéntrico con un grupo control

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TESEO

Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

ADAM

Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

SMART

Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test

MalTransc

Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses

GenMoz

P. falciparum genomic intelligence in Mozambique

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa

RESPONSE

Mechanisms of the transcriptional responses to changes in the environment in the malaria parasite Plasmodium falciparum

VivaxEVTalk

Extracellular Vesicles as Intercellular Communicators and Biomarkers of Cryptic Erythrocytic Infections in Plasmodium vivax malaria

VaMonoS

Unravelling the heterogoneity and function of monocytes in vaccination and immunity to malaria

CLIMSOCTRYPBOL

Insight on climate and social participatory research for integral management of vectorborne zoonosis caused by Trypanosoma cruzi and Leishmania spp. in the Bolivian Gran Chaco.

SexMal

Social affairs and sex in P. falciparum: implications for malaria elimination

MENA Migrant Health

Transforming data collection and surveillance to drive migrant health research, care and policy

MESA

La Alianza Científica para la Erradicación de la Malaria (MESA) tiene como objetivo avanzar en la ciencia de la erradicación de la malaria.